Dr. Finelli completed his urology residency in 2003 at the University of Toronto and became a Fellow of the Royal College of Physicians and Surgeons. During his residency, he earned a Masters of Science degree through the Surgical Scientist Program. Before joining the Faculty in 2005, he completed a fellowship in Laparoscopic Urologic Oncology at the Cleveland Clinic Foundation. His clinical practice focuses on the management of urologic malignancies with minimally invasive techniques. Specifically, he performs laparoscopic radical prostatectomy, nephrectomy, partial nephrectomy and adrenalectomy. His research interest is the assessment of new surgical technology.
Graduated from University of Toronto, Faculty of Medicine, and completed his urology training at The University of Toronto. He became a Fellow of the Royal College of Physicians and Surgeons of Canada in 1993 and subsequently spent 2 years as a Fellow and 1 year as a staff physician at Memorial Sloan Kettering Cancer Center in New York City. During his tenure in New York, he also completed a Masters Degree in Epidemiology at the School of Public Health at Columbia University. He is now Chief of Urology at the UHN. His clinical practice is in urologic oncology with research interests in prostate and bladder cancer.
Dr. Robert Hamilton completed his medical school and urology residency at the University of Toronto. During his residency he earned a Masters of Public Health (MPH) from the University of North Carolina at Chapel Hill and completed a research fellowship at Duke University. Before joining the Faculty, he completed a fellowship in Urologic Oncology at Memorial Sloan-Kettering Cancer Center in New York City. His clinical practice encompasses all genitourinary malignancies, with special interest in prostate and testis cancer, as well as minimally invasive surgery including robotic surgery. His research interests focus on epidemiology and biomarkers in predicting risk and progression of these cancers.
Graduated from Queen's University, Faculty of Medicine, and completed his urology training at The University of Toronto. He became a Fellow of the Royal College of Physicians and Surgeons of Canada in 1974 and subsequently spent 2 years as a Fellow at Memorial Sloane Kettering Cancer Center in New York City before returning to the Faculty. His clinical practice is in urologic oncology with research interests in testicular cancer and superficial bladder cancer.
Dr. Girish Kulkarni completed his medical school and residency in urology at the University of Toronto. During his residency, he entered the Surgeon-Scientist program and completed his PhD in Clinical Epidemiology through the Department of Health Policy, Management and Evaluation at the Institute for Clinical Evaluative Sciences (ICES). He then completed a fellowship in Urologic Oncology at Memorial Sloan-Kettering Cancer Center in New York City. He joined the faculty at the University of Toronto in 2011. His primary research interests involve the epidemiology of genitourinary malignancies, particularly bladder and prostate cancer.
Dr. John Trachtenberg received his B.Sc., M.D. & C.M. from McGill University in Montreal. He completed his urologic residency at McGill University and succeeded to a fellowship in prostatic disease at Johns Hopkins University. Dr. Trachtenberg is currently Professor of Surgery and Medical Imaging at the University of Toronto. He holds the prestigious Fleck Tanenbaum Chair in Prostatic Diseases at the University of Toronto and University Health Network. He is the Director of the Prostate Centre at The Princess Margaret of the University Health Network He acts as a consultant to the Urology Department at numerous hospitals. Dr. Trachtenberg has published over 225 peer reviewed scientific papers and several books, and sits on many hospital, university and scientific committees throughout North America and Europe. His accomplishments have earned him 18 awards, including Man of the Year in Sciences and Medicine from the Canadian Prostate Cancer Research Program at The Princess Margaret. His major interests include the investigation of novel treatments for localized and advanced prostate cancer, developing minimally invasive image guided treatments for prostate cancer, and the measurement and preservation of the quality of life of men with prostate cancer.
Since 2006 when he came from Belgium, Dr. Alexandre Zlotta has been a Professor in the Department of Surgery (Urology) at the University of Toronto, Director of Uro-Oncology at Mount Sinai Hospital, Toronto, and Staff at Princess Margaret -Toronto General Hospitals/ University Health Network. He is an Associate Editor for European Urology, the leading urology journal world-wide and is on the editorial board of several international journals. Dr. Zlotta received his medical degree, urology training and PhD degree at the University of Brussels, Belgium. He was awarded -among other awards-the prestigious EAU Matula Award in 2000. Dr. Zlotta is an uro-oncologic surgeon, currently performing research on prostate and bladder cancer. He is the PI or co-PI of several large-scale International Research Projects. He has been a board member of the Scientific Committee of the European Association of Urology, the European Society of Oncological Urology, the Scientific Committee of the Belgian Association of Urology, the Belgian National College of Oncology and member of the National Cancer Institute of Canada- Prevention Initiative. He is currently a steering Committee Member of the North American Bladder Cancer Think Tank, BCAN.